Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

SQ-29548

Thromboxane receptor ligand
 
BML-RA103-0001 1 mg 92.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-340-016

Potent, selective thromboxane A2 receptor antagonist. Shows inhibition of human platelet aggregation initiated by arachidonic acid (IC50=12nM) . Ki=7.9 nM for inhibition of [3H]-U-46619 binding to human platelet membranes.

Product Specification

Alternative Name:[1S-[1α,2α(Z),3α,4α]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptanoic acid]
 
Formula:C21H29N3O4
 
MW:387.5
 
CAS:98672-91-4
 
Purity:≥98% (HPLC)
 
Appearance:White to off-white crystalline powder.
 
Solubility:Soluble in 100% ethanol, methanol or acetonitrile; also soluble in PBS, pH 7.2, DMSO or dimethyl formamide.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Handling:Hygroscopic.
 
Technical Info/Product Notes:Note: Product is not sterile.
 
Regulatory Status:RUO - Research Use Only
 
bml-ra103
Please mouse over
bml-ra103

Product Literature References

Effect of hypoxia in mice mesenteric arteries surrounded by adipose tissue: N. Maenhaut, et al.; Acta Physiol. (Oxf.) 203, 235 (2011), Abstract;
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells: M. Fukunaga, et al.; Am. J. Physiol. 264, C1619 (1993), Abstract;
7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors: M. Naka, et al.; J. Pharmacol. Exp. Ther. 262, 632 (1992), Abstract;
Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes: H. Monshizadegan, et al.; Life Sci. 51, 431 (1992), Abstract;
Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells: J.A. Hunt, et al.; Biochem. Pharmacol. 43, 1747 (1992), Abstract;
Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles: M.L. Ogletree & G.T. Allen; J. Pharmacol. Exp. Ther. 260, 789 (1992), Abstract;
PgH2 analogs as potential antiplatelet derivatives: D. Komiotis, et al.; J. Med. Chem. 35, 3033 (1992), Abstract;
Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548): E.J. Kattelman, et al.; Thromb Res. 41, 471 (1986), Abstract;
Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist: M.L. Ogletree, et al.; J. Pharmacol. Exp. Ther. 234, 435 (1985), Abstract;

Recommend this page

 
Keep in touch

©2020 Enzo Life Sciences, Inc.,